Oncolytics Biotech (NASDAQ:ONCY) Rating Reiterated by HC Wainwright
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a note issued to investors on Thursday, Benzinga reports. They currently have a $5.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 441.18% from the company’s current price. Oncolytics […]
More Stories
Sudan: UN chief alarmed at full-scale assault on El Fasher
The UN Secretary-General is gravely alarmed by reports of a full-scale assault on El Fasher by the Rapid Support Forces...
Lennar (NYSE:LEN) Issues Quarterly Earnings Results, Beats Estimates By $0.28 EPS
Lennar (NYSE:LEN – Get Free Report) posted its quarterly earnings results on Thursday. The construction company reported $3.90 earnings per...
Secret Service, Homeland Security Sued Over Records Related to Trump Assassination Attempt
By Jack Phillips A lawsuit was filed against the U.S. Secret Service and Department of Homeland Security (DHS) in a...
Trump Proposes Temporary 10 Percent Cap on Credit Card Interest Rates
By Andrew Moran Former President Donald Trump has proposed a 10 percent temporary cap on credit card interest rates, which...
A Particular Bacteria in Your Urine Can Help Protect Against Kidney Stones
By Rachel Ann T. Melegrito The urinary tract microbiome, also known as the urobiome, is home to various microorganisms. Researchers...
Cracker Barrel Old Country Store (NASDAQ:CBRL) Announces Earnings Results
Cracker Barrel Old Country Store (NASDAQ:CBRL – Get Free Report) released its quarterly earnings data on Thursday. The restaurant operator...